Loading companies…
Loading companies…
China · Biotech · AI · Enterprise software
Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D | $55M | Biometas — Role not disclosedBioVeda China Fund (BVCF) — Role not disclosedDetong Capital — Role not disclosedFuzhou Xinhe Fund — Role not disclosedJiashan State VC — Role not disclosedKeyuan Pharma — Role not disclosedShanghai Pudong Leading Area Investment Center — Role not disclosedShanghai Puxing Collaborative Private Equity Fund Partnership Enterprise — Role not disclosedShenzhen Luohu Donghai Chempartner Investment Fund — Role not disclosedTukar Capital — Role not disclosedWedo Capital — Role not disclosedYD Capital — Role not disclosed |